Clinical characteristics and disease course before and after SARS-CoV-2 infection in a large cohort of systemic sclerosis patients.
Aslıhan Avanoglu GülerBüşra ÖzçimenMesude Seda AydoğduAlper SariAliyeva NumuneNazife Tüzün ErsanSeda YurumezHazan Karadenizİbrahim VasiHamit KucukYasemin YalcinkayaAbdulsamet ErdenMehmet KayaalpMehmet Akif OzturkBerna GökerAhmet OmmaSedat YilmazSuleyman Serdar KocaMurat InançAli AkdoganAbdurrahman TufanPublished in: Turkish journal of medical sciences (2023)
This study suggests a potential association between adverse outcomes of COVID-19 and SSc-related ILD, severe disease activity, and the use of mycophenolate. Additionally, it highlights that having comorbidities is an independent risk factor for the need for respiratory support in COVID-19 cases.
Keyphrases
- systemic sclerosis
- interstitial lung disease
- disease activity
- coronavirus disease
- rheumatoid arthritis
- sars cov
- end stage renal disease
- systemic lupus erythematosus
- rheumatoid arthritis patients
- newly diagnosed
- ejection fraction
- chronic kidney disease
- respiratory syndrome coronavirus
- ankylosing spondylitis
- peritoneal dialysis
- juvenile idiopathic arthritis
- prognostic factors
- early onset
- patient reported outcomes
- idiopathic pulmonary fibrosis